Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
United States: 1-888-708-7444 or 1-919-852-4685
France: +33 1 56 95 17 10
Germany: +49 89 45 10 300
United Kingdom: +44 (0) 114 292 2322
India: +91 984 500 6625
Interested in Certara's biosimulation solutions? Want to speak to someone in our sales team? Click on the link below!
Certara has broad expertise in endocrine diseases including diabetes, obesity, hypogonadism, and hypoparathyroidism. For example, our scientists supported more than 50 diabetes development programs for industry clients over the past eight years, from pre-clinical to Phase IV commercial strategy. Our consultants have addressed critical issues in trial design, dose selection, extrapolation from animal to human, and development strategy for the major classes of diabetes therapies. We performed 15 projects in 2012 including population dose-response and PK/PD analyses of efficacy and safety biomarker data, dose selection for renally impaired patients and long-term forecasting of HbA1c levels.
Our extensive knowledge and compilations of public data from the clinical and scientific literature for endocrine diseases provide a ready context for model-based meta-analysis to assess your compound's performance against competing therapies.
By partnering with Certara Strategic Consulting, you can leverage the power of biosimulation technology to get your drug to market faster.